analyst-ratings

ServiceNow stock jumps 5.45% after unveiling strategy to reach $30B annual subscription revenue by 2030, with AI monetization driving growth.

Palantir crushed Q1 earnings with 85% revenue growth and Rule of 40 score of 145%, but stock fell 7% on valuation worries despite raised guidance.

DexCom beats Q1 earnings with $1.2B revenue, boasts 20 Buy ratings. New products and margin expansion drive 40% upside potential.

Three telecom equipment makers delivered 1,000%+ returns in a year, vastly outpacing Nvidia's 75% gain, driven by hyperscaler datacenter expansion.

Eli Lilly stock near $960 has 26% upside to $1,215 consensus target, driven by blockbuster GLP-1 drugs Mounjaro and Zepbound delivering 60% revenue growth.

Palantir shares rise 2.23% pre-earnings on AI Platform momentum and $300M USDA deal, though analyst sentiment remains mixed with price targets ranging from $210 to $230.

Analysts warn of significant downside for Marvell Technology and Navitas Semiconductor amid valuation concerns and sector transitions, despite bullish long-term outlooks.

Beyond Meat stock surged 20.7% Thursday to $0.98, gaining another 2.6% overnight. Despite the rally, shares remain down 60% yearly near 52-week lows, with Q1 earnings due May 6.

Alphabet surges 7.8% on strong Q1 results: $109.9B revenue (+22% YoY), 63% Google Cloud growth, $460B backlog nearly doubles.

$SPOT beats EPS but misses revenue as AI investments weigh on profits; analysts maintain bullish stance on long-term growth potential.

Micron shares fell 2.6% after OpenAI missed targets, raising AI demand concerns. Analysts maintain buy ratings with $600-$1,000 price targets, citing sustained memory chip demand.

Taiwan Semiconductor and ASML Holding show resilience with 20-26% upside potential through 2026, buoyed by strong earnings and analyst support despite equipment spending concerns.

$BE surges 14.3% on analyst upgrades and Oracle partnership expansion, though Q1 2026 earnings could trigger sharp reversal if guidance missed.

Wall Street analysts strongly favor $APPL over $TTD, citing superior growth despite premium valuation. AppLovin maintains 70% YoY growth with 30 buy ratings versus Trade Desk's struggling 14% Q4 expansion.

Amazon stock surges 30% to $250 on AI optimism and strategic acquisitions, but technical indicators signal overbought conditions ahead of earnings.

RTX faces Trump buyback restrictions but analysts see 20% upside through 2026, supported by $271B backlog and strong Q1 earnings growth.

Alphabet's 10% stock decline over $185B AI spending concerns may represent a buying opportunity given the company's dominant market positions and $126.8B cash reserves.

Nebius stock surged 8.8% on BofA's $150-to-$175 price target hike, though Freedom Capital simultaneously downgraded the stock, signaling divergent analyst views.

MAMA stock shows strong fundamentals with 60%+ revenue growth and 77.4% EBITDA expansion. All six analysts rate Buy with $20 target; institutions own 45% and accumulating.

Wall Street predicts 70%+ gains for Nebius and Linde as AI infrastructure plays, while downgrading C3.ai on collapsing revenue amid market repricing.